Fresenius | FRE - Market Capitalization

Stock Price
51.41
Daily Change
-0.31 -0.60%
Monthly
6.95%
Yearly
40.62%
Q1 Forecast
50.68

Fresenius reported EUR29.31B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akzo Nobel EUR 9.74B 626.11M Feb/2026
Alcon AG USD 29.11B 5.61B Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
BASF EUR 37.83B 473.04M Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
DaVita Healthcare Partners USD 11.27B 3.48B Feb/2026
Demant DKK 40.69B 5.32B Feb/2026
E.ON EUR 41.82B 990M Sep/2025
Essilor EUR 113.92B 11.13B Feb/2026
Fresenius EUR 26.7B 2.66B Sep/2025
Fresenius Medical Care EUR 13.1B 1.17B Sep/2025
Givaudan CHF 35.47B 1.15B Jun/2025
GlaxoSmithKline GBP 87.33B 12.98B Feb/2026
GN Store Nord DKK 13.76B 2.35B Feb/2026
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Philips EUR 24.21B 1.83B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
RWE EUR 27.43B 1.23B Sep/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Smith & Nephew USD 3.93B 9.39B Jan/2026